reports
- Jonathan Moreland
Simply Good Foods to Report Fourth Quarter and Full Fiscal Year 2024 F...
Simply Good Foods to Report Fourth Quarter and Full Fiscal Year 2024 Financial Results on Thursday, October 24, 2024 DENVER, Oct. 01, 2024 (GLOBE NEWSWIRE) -- The Simply Good Foods Company (NASDAQ: SMPL) (“Simply Good Foods” or the “Company”), a developer, marketer and seller of branded nutritional foods and snacking products, today announced it will report financial results for the 14 week fiscal fourth quarter and full fiscal year ended August 31, 2024, on Thursday, October 24, 2024, before market open. The Company will host a conference call to discuss these results with additional com...
Axsome Therapeutics Presents Data from Multiple Programs at Sleep Euro...
Axsome Therapeutics Presents Data from Multiple Programs at Sleep Europe 2024 Seven presentations highlight the Company’s growing CNS portfolio and commitment to improving treatment outcomes for patients with sleep disorders NEW YORK, Sept. 24, 2024 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, today announced seven presentations on AXS-12 and solriamfetol at Sleep Europe 2024, the 27th Congress of the European Sleep Research Society, being ...
OPKO Health’s ModeX Therapeutics Appoints Dr. Giovanni Abbadessa as Ch...
OPKO Health’s ModeX Therapeutics Appoints Dr. Giovanni Abbadessa as Chief Medical Officer as Pipeline Advances into Clinical Development WESTON, Mass., Sept. 23, 2024 (GLOBE NEWSWIRE) -- ModeX Therapeutics Inc., an OPKO Health, Inc. (NASDAQ: OPK) company, today announced the appointment of Giovanni Abbadessa, M.D., Ph.D. as Chief Medical Officer, a newly created position. Dr. Abbadessa has over two decades of experience in drug development, including most recently as Vice President at Sanofi, where he provided executive leadership for advancing oncology assets. “Dr. Abbadessa’s deep ...
- Dave Nicoski
- Ross LaDuke
Vital Signs: Actionable charts
In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
AAON AAON INC.
XHR XENIA HOTELS & RESORTS INC.
WLDN WILLDAN GROUP
TSLA TESLA INC
TPC TUTOR PERINI CORPORATION
STRL STERLING CONSTRUCTION COMPANY INC.
RYAM RAYONIER ADVANCED MATERIALS INC
RLJ RLJ LODGING TRUST
PYPL PAYPAL HOLDINGS INC
PWR QUANTA SERVICES INC.
POWL POWELL INDUSTRIES INC.
PLCE CHILDREN'S PLACE INC.
MTZ MASTEC INC.
MOD MODINE MANUFACTURING COMPANY
INN SUMMIT HOTEL PROPERTIES INC.
CLDT CHATHAM LODGING TRUST
AAOI APPLIED OPTOELECTRONICS INC.
DRI DARDEN RESTAURANTS INC.
ITT ITT INC.
AGX ARGAN INC.
TG TREDEGAR CORP.
PNRG PRIMEENERGY RESOURCES
TAYD TAYLOR DEVICES INC.
TPB TURNING POINT BRANDS
USLM U.S. LIME & MINERALS
WLFC WILLIS LEASE FINANCE CORP.
USAP UNIVERSAL STAINLESS & ALLOY PRODUCTS INC.
PK PARK HOTELS & RESORTS INC.
ROAD CONSTRUCTION PARTNERS
BELFA BEL FUSE INC. CL A
AXR AMREP
SITM SITIME
IESC IES HOLDINGS INC.
VRDN VIRIDIAN THERAPEUTICS INC
COMM BMO GLOBAL COMMUNICATIONS INDEX ETF
JXN JACKSON FINANCIAL INC
PCT PURECYCLE TECHNOLOGIES INC
COHR COHERENT CORP
MBC_w MASTERBRAND INC
CRVO CERVOMED INC
DAVE DAVE INC
SOC SABLE OFFSHORE CORP
FTCO FORTITUDE GOLD
DOGZ DOGNESS INTERNATIONAL CORP
- Jonathan Moreland
PENN PENN NATIONAL GAMING INC.
PAYC PAYCOM SOFTWARE INC.
MTDR MATADOR RESOURCES COMPANY
GLP GLOBAL PARTNERS LP
CODI COMPASS DIVERSIFIED HOLDINGS
FIVN FIVE9 INC.
FRD FRIEDMAN INDUSTRIES INC.
APTV APTIV PLC
APPN APPIAN
ZM ZOOM VIDEO COMMUNICATIONS
ETON INC.
INBX ETON PHARMACEUTICALS
PET INHIBRX
LUNR INC.
SYRS WAG GROUP CO
PEO INTUITIVE MACHINES INC
XPER SYROS PHARMACEUTICALS INC.
PETROLEUM & RESOURCES CORPORATION
XPERI INC
- Jonathan Moreland
PSEC PROSPECT CAPITAL CORPORATION
PBF PBF ENERGY INC. CLASS A
PAYC PAYCOM SOFTWARE INC.
MTDR MATADOR RESOURCES COMPANY
CTRN CITI TRENDS INC.
RLMD RELMADA THERAPEUTICS
CULP CULP INC.
MYRG MYR GROUP INC.
HLT HILTON WORLDWIDE HOLDINGS INC
CNX CONSOL ENERGY INC.
ZM ZOOM VIDEO COMMUNICATIONS
GRNT INC.
FTHY GRANIT SKOPKE
PFHC FIRST TRUST HIGH YIELD OPPORTUNITIES 2027 TERM FUND
GNLX PROFRAC HLDG CORP
NPWR GENELUX CORP
PEO NET POWER INC
PETROLEUM & RESOURCES CORPORATION
The Simply Good Foods Company Names Mike Clawson as Chief Customer Off...
The Simply Good Foods Company Names Mike Clawson as Chief Customer Officer DENVER, Sept. 09, 2024 (GLOBE NEWSWIRE) -- The Simply Good Foods Company (Nasdaq: SMPL) (“Simply Good Foods,” or the “Company”), a developer, marketer and seller of branded nutritional foods and snacking products, today announced Mike Clawson as Chief Customer Officer (“CCO”), effective October 14, 2024. As the Company embarks on its next chapter of growth, a cornerstone of its strategic growth plan is an enhanced selling model and approach. This new sales playbook is centered on building multi-year growth plans...
- Jonathan Moreland
Axsome Therapeutics Announces FDA Acceptance of NDA Resubmission for A...
Axsome Therapeutics Announces FDA Acceptance of NDA Resubmission for AXS-07 for the Acute Treatment of Migraine FDA sets PDUFA action goal date of January 31, 2025 NEW YORK, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, today announced that the U.S. Food and Drug Administration (FDA) has acknowledged the resubmission of the Company’s New Drug Application (NDA) for AXS-07 for the acute treatment of migraine. The FDA designated ...
Axsome Therapeutics to Participate in Investor Conferences in Septembe...
Axsome Therapeutics to Participate in Investor Conferences in September Morgan Stanley 22nd Annual Global Healthcare Conference on September 4 in New York Wells Fargo Healthcare Conference on September 5 in Boston Baird 2024 Global Healthcare Conference on September 11 in New York Cantor Global Healthcare Conference on September 18 in New York NEW YORK, Aug. 27, 2024 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, will participate in...
- Jonathan Moreland
OEC ORION ENGINEERED CARBONS SA
ZM ZOOM VIDEO COMMUNICATIONS
GRX INC.
HYZN THE GABELLI HEALTHCARE & WELLNESSRX TRUST
BIGZ HYZON MOTORS INC.
VFC BLACKROCK INNOVATION AND GROWTH TST
MIO VF CORPORATION
PEO PIONEER MUN HIGH INCOME OPPORTUNITIES FD INC
SUNS PETROLEUM & RESOURCES CORPORATION
SUNRISE REALTY TRUST
Axsome Therapeutics Reaches Agreement to Dismiss Sunosi® (Solriamfetol...
Axsome Therapeutics Reaches Agreement to Dismiss Sunosi® (Solriamfetol) Patent Litigation with Sandoz Inc. NEW YORK, Aug. 21, 2024 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system disorders, today announced that it has reached agreement with Sandoz Inc. (Sandoz) to dismiss the patent litigation related to Axsome’s product Sunosi® (solriamfetol). The litigation, which was pending in the United States District Court for the District of New Jersey, resulted from sub...
- Jonathan Moreland
RHP RYMAN HOSPITALITY PROPERTIES INC.
PBPB POTBELLY CORP.
PBF PBF ENERGY INC. CLASS A
PAYC PAYCOM SOFTWARE INC.
OEC ORION ENGINEERED CARBONS SA
NEOG NEOGEN CORPORATION
INTC INTEL CORPORATION
CRK COMSTOCK RESOURCES INC.
MEDP MEDPACE HOLDINGS INC.
NINE NINE ENERGY SERVICE INC
VCNX VACCINEX
PFIS PEOPLES FINANCIAL SERVICES CORP.
ZM ZOOM VIDEO COMMUNICATIONS
TSLX INC.
MPLN SIXTH STREET SPECIALTY LENDING
GEVO INC.
CTOS MULTIPLAN CORP CLASS A
RPID GEVO
GLSI CUSTOM TRUCK ONE SOURCE
INC.
RAPID MICRO BIOSYSTEMS INC
GREENWICH LIFESCIENCES INC
OPKO Health Reports Second Quarter 2024 Business Highlights and Financ...
OPKO Health Reports Second Quarter 2024 Business Highlights and Financial Results Conference call begins at 4:30 p.m. Eastern time today MIAMI, Aug. 07, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three and six months ended June 30, 2024. Highlights from the second quarter and recent weeks include the following: Enrollment underway in the MDX2001 Phase 1 trial for the treatment of solid tumor cancers. MDX2001, a tetraspecific antibody, is designed to optimize T-cell function to stimulate tumor regression while mini...
Axsome Therapeutics Reports Second Quarter 2024 Financial Results and ...
Axsome Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update Total 2Q 2024 net product revenue of $87.2 million, representing 87% year-over-year growth Auvelity® 2Q 2024 net product sales of $65.0 million, representing 135% year-over-year growth Sunosi® 2Q 2024 net product revenue of $22.1 million representing 16% year-over-year growth NDA for AXS-07 in migraine resubmitted Topline results of ADVANCE-2 Phase 3 trial of AXS-05 in Alzheimer’s disease agitation anticipated 2H 2024 Topline results of ACCORD-2 Phase 3 randomized withdrawal trial of AXS-05 ...
OPKO Health to Report Second Quarter 2024 Financial Results on August ...
OPKO Health to Report Second Quarter 2024 Financial Results on August 7, 2024 MIAMI, Aug. 01, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three and six months ended June 30, 2024 after the close of the U.S. financial markets on Wednesday, August 7, 2024. OPKO’s senior management will provide a business update and discuss results as well as financial guidance during a conference call and live audio webcast on August 7th beginning at 4:30 p.m. Eastern time. CONFERENCE CALL & WEBCAST INFORMATION OPKO encourages participan...
- Jonathan Moreland
- Jonathan Moreland
OPKO Health Announces $100 Million Share Repurchase Program
OPKO Health Announces $100 Million Share Repurchase Program MIAMI, July 18, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced that its Board of Directors has authorized the repurchase of up to $100 million of shares of the Company's common stock. Under the repurchase program, OPKO may repurchase shares of its common stock from time to time through open market purchases, block trades, privately negotiated transactions, accelerated share repurchase transactions and/or pursuant to Rule 10b5-1 plans, in compliance with applicable securities laws and other legal requir...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.